SSB
ARMP icon

Sandy Spring Bank’s Armata Pharmaceuticals ARMP Stock Holding History

Sandy Spring Bank’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,082
Closed -$4K – 1214
2021
Q3 		$4K Hold
1,082
– – ﹤0.01% 989
2021
Q2 		$4K Buy
1,082
+711
+192% +$2.99K ﹤0.01% 992
2021
Q1 		$2K Sell
371
-629
-63% -$3.09K ﹤0.01% 936
2020
Q4 		$3K Buy
1,000
+300
+43% +$953 ﹤0.01% 851
2020
Q3 		$2K Buy
700
+100
+17% +$352 ﹤0.01% 790
2020
Q2 		$2K Buy
600
+100
+20% +$347 ﹤0.01% 822
2020
Q1 		$2K Buy
+500
New +$1.72K ﹤0.01% 815

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sandy Spring Bank's ARMP Position: Q4 2021 in Review

Sandy Spring Bank sold out of Armata Pharmaceuticals (ARMP) in Q4 2021, closing a stake of 1,082 shares — an estimated $4K sold.

Sandy Spring Bank first reported a position in ARMP in Q1 2020 and held it in 7 quarters. The position peaked at $4K in Q3 2021. 17 funds tracked by Wall St. Rank hold ARMP as of Q4 2021.

  • Sandy Spring Bank reported no remaining Armata Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Sandy Spring Bank sold 1,082 Armata Pharmaceuticals shares in Q4 2021, an estimated $4K.
  • Sandy Spring Bank first reported a position in Armata Pharmaceuticals in Q1 2020 and held it in 7 quarters.
  • Sandy Spring Bank's Armata Pharmaceuticals position peaked at $4K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2021.

Based on Sandy Spring Bank's 13F filing for Q4 2021, filed 11 Feb 2022.